Nav: Home

Study examines opioid use among Massachusetts adolescents, trends in opioid prescriptions

November 13, 2018

Opioid-related overdoses and deaths remain a major public health concern in Massachusetts, yet adolescents who experience opioid-related nonfatal overdose (NFOD) have been rarely studied. Using public data, Brigham investigators recently unearthed several important ways in which the opioid crisis is playing out differently among young people versus adults.

Performed in collaboration with colleagues at the Boston University School of Medicine and Massachusetts Department of Public Health, the analysis examined data on adolescents in Massachusetts, ages 11 to 17, who experienced an opioid-related nonfatal overdose between 2012 and 2014. In addition to understanding how prevalent these events were in young people compared to adults, researchers also found differences in how adolescents receive medication to treat opioid use disorder after experiencing a nonfatal overdose. The team's results were recently published in Drug and Alcohol Dependence.

Among the findings were that adolescent girls were more likely to experience an opioid-related nonfatal overdose - the opposite of what has been observed in adults - although the reasons for this remain unclear. Additionally, investigators discovered these events were, overall, far less common in young people in the period studied, occurring in 195 adolescents versus 22,311 adults.

"This evidence will help guide the conversation about adolescent opioid abuse. In a lot of ways, this study raises more questions than answers, such as why more adolescent girls are overdosing than boys," said Avik Chatterjee, MD, MPH, first author and associate epidemiologist in the Division of Global Health Equity at the Brigham. "The ability to bring attention to a population that has been understudied with regard to the opioid epidemic will help researchers and physicians explore ways to treat this epidemic in adolescence."

An opioid-related nonfatal overdose occurs when an individual uses an opioid, sometimes in conjunction with other drugs, and becomes mentally altered or sedated to the point that immediate, lifesaving treatment is necessary.

"A nonfatal overdose might be an opportunity to intervene," said Chatterjee. "People are using opioids so much that they are at risk of dying, so this could be a time when health care professionals could step in and help the person obtain treatment before a fatal overdose occurs."

To examine the adolescent and adult NFOD rates in Massachusetts, researchers analyzed data from 2012 to 2014, pooled from the entire state as part of Chapter 55 of the Acts of 2015. This dataset represents 98 percent of Massachusetts residents and includes non-identifiable medical information from hospitals, ambulance systems, substance-use systems, health insurance companies and homeless shelters.

Researchers were interested in examining whether adolescents received medication - methadone, buprenorphine or naltrexone - to treat an opioid use disorder within 12 months of experiencing a nonfatal overdose. They found that only 8 percent of adolescents were prescribed one of these medications within a year of the overdose.

"Adolescents have not received as much focus as adults in the opioid crisis," said senior author Sarah Bagley, MD, an assistant professor and primary care physician at Boston Medical Center. "However, these data illustrate that in Massachusetts, adolescents have not been spared and that they are not receiving timely treatment."

The authors note that these numbers may be low because many people now have access to opioid overdose reversal drugs outside of a health care setting.

"This analysis took advantage of a unique tool developed by the Massachusetts Department of Public Health (DPH) to enable us to access linked, multi-year data for analysis of fatal and non-fatal opioid overdoses, as well as for other health priorities and trends," said Dana Bernson, DPH Assistant Director, Special Analytic Projects. "These results highlight the importance of our partnerships with researchers from academic, non-profit, private and government agencies in using data to respond to the opioid epidemic."
-end-
Funding for this work was provided by the National Center for Advancing Translational Sciences (1K23 DA044324-01 and 1UL1TR001430), National Institute for Drug Abuse (K23 DA042168, K23 DA045085 and L40 DA042434) a Boston University School of Medicine Department of Medicine Career Investment Award, a Thrasher Research Fund Early Career Award and an Academic Pediatric Association Young Investigator Award.

Paper cited: Chatterjee, A et al. "Non-fatal opioid-related overdoses among adolescents in Massachusetts 2012-2014" Drug and Alcohol Dependence DOI: https://doi.org/10.1016/j.drugalcdep.2018.09.020

Trends in Opioid Prescriptions in Children, Adolescents Brain Bateman, MD, researcher at Brigham and Women's Hospital, found prescription opioids provided to children and adolescents have steadily decreased since 2012 in an analysis of data from a large commercial insurance provider.

In 2004, three out of 1,000 kids had received an outpatient opioid prescription in a given month, which then increased to four per 1,000 between 2009 to 2012 before dropping to two of every 1,000 at the start of 2017. The trend in long-term opioid prescription use (three or more consecutive months) also similarly declined.

Data for this analysis came only from a single large commercial insurance provider, and the authors note opioid dispensing rates may differ in other populations and settings.

Paper cited: Bateman, B et al. "Trends in Opioid Prescription in Children and Adolescents in a Commercially Insured Population in the United States, 2004-2017". JAMA Pediatrics DOI: 10.1001/jamapediatrics.2018.3668

Brigham and Women's Hospital

Related Public Health Articles:

Public health guidelines aim to lower health risks of cannabis use
Canada's Lower-Risk Cannabis Use Guidelines, released today with the endorsement of key medical and public health organizations, provide 10 science-based recommendations to enable cannabis users to reduce their health risks.
Study clusters health behavior groups to broaden public health interventions
A new study led by a University of Kansas researcher has used national health statistics and identified how to cluster seven health behavior groups based on smoking status, alcohol use, physical activity, physician visits and flu vaccination are associated with mortality.
Public health experts celebrate 30 years of CDC's prevention research solutions for communities with health disparities
It has been 30 years since CDC created the Prevention Research Centers (PRC) Program, currently a network of 26 academic institutions across the US dedicated to moving new discoveries into the communities that need them.
Public health experts support federally mandated smoke-free public housing
In response to a new federal rule mandating smoke-free policies in federally funded public housing authorities, three public health experts applaud the efforts of the US Department of Housing and Urban Development to protect nonsmoking residents from the harmful effects of tobacco exposure.
The Lancet Public Health: UK soft drinks industry levy estimated to have significant health benefits, especially among children
The UK soft drinks industry levy, due to be introduced in April 2018, is estimated to have significant health benefits, especially among children, according to the first study to estimate its health impact, published in The Lancet Public Health.
More Public Health News and Public Health Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...